High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
暂无分享,去创建一个
D Pinkel | S. Pulst | D. Pinkel | D. Albertson | R. Segraves | J. Zucman‐Rossi | C. Möller | D. Evans | E. Blennow | C. Bruder | J. Dumanski | G. Hamilton | I. Fransson | G. Rouleau | L. Kluwe | V. Mautner | M. Niimura | M. Baser | E. Boltshauser | I. Tapia-Páez | M. Sainio | A. Jordanova | D. Albertson | A. Wallace | L. Papi | G. Hung | E Boltshauser | A Heiberg | G A Rouleau | E Blennow | C. Hirvelä | X. X. Zhang | M. Hergersberg | G. Poptodorov | H. Rask-Andersen | T. Mathiesen | C. Möller | H. Harder | A. Heiberg | M. Honda | S. Sahlén | M E Baser | D G Evans | J P Dumanski | T. Mathiesen | G Hung | S M Pulst | H Rask-Andersen | I Fransson | L Kluwe | C E Bruder | C Hirvelä | I Tapia-Paez | R Segraves | G Hamilton | X X Zhang | A J Wallace | J Zucman-Rossi | M Hergersberg | L Papi | G Poptodorov | A Jordanova | V Mautner | M Sainio | T Mathiesen | C Möller | H Harder | M Honda | M Niimura | S Sahlén | D G Albertson | Henrik Harder | G. Poptodorov | A. Wallace | Gene Hung | D. Evans | D. Evans | Xiao Xiao Zhang | D. Evans | D. Evans | D. Evans
[1] D. Evans,et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. , 1992, Journal of medical genetics.
[2] W. Kuo,et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.
[3] S. Pulst,et al. Neurofibromatosis 2 in the pediatric age group. , 1993, Neurosurgery.
[4] D. Evans,et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. , 1992, Journal of medical genetics.
[5] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[6] L. Gaunt,et al. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. , 1993, Human molecular genetics.
[7] S. Pulst,et al. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes , 1996, Neurology.
[8] D. Evans,et al. A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.
[9] E. Blennow,et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4‐MB constitutional deletion on chromosome 22: Possible localization of a neurofibromatosis type 2 modifier gene? , 1999, Genes, chromosomes & cancer.
[10] Melanie E. Goward,et al. The DNA sequence of human chromosome 22 , 1999, Nature.
[11] R. Weksberg,et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.
[12] M. Kaiser-Kupfer,et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.
[13] L. Kluwe,et al. Mosaicism in sporadic neurofibromatosis 2 patients. , 1998, Human molecular genetics.
[14] D. Evans,et al. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. , 1998, Journal of medical genetics.
[15] M I Kaiser-Kupfer,et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. , 1994, American journal of medical genetics.
[16] J. Dumanski,et al. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers , 1993, Neurology.
[17] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[18] P. Dejong,et al. Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12. , 1993, Human molecular genetics.
[19] V. P. Collins,et al. Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene. , 1994, Human molecular genetics.
[20] B. Roe,et al. Fine mapping of the constitutional translocation t(11;22)(q23;q11) , 2000, Human Genetics.
[21] N. Carter,et al. Fifty probands with extra structurally abnormal chromosomes characterized by fluorescence in situ hybridization. , 1995, American journal of medical genetics.
[22] B. Korf,et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, Journal of the American Medical Association (JAMA).
[23] D. Evans,et al. Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis. , 1998, American journal of human genetics.
[24] S. Pulst,et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.
[25] D. Evans,et al. Misleading linkage results in an NF2 presymptomatic test owing to mosaicism. , 1997, Journal of medical genetics.
[26] M. Sanson,et al. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. , 1993, Human molecular genetics.
[27] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.
[28] F. Sor,et al. NF2 gene in neurofibromatosis type 2 patients. , 1998, Human molecular genetics.
[29] R Eldridge,et al. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). , 1988, The New England journal of medicine.
[30] L. Kluwe,et al. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes , 1996, Human Genetics.
[31] E. Constant. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 , 1998 .
[32] K. Hoang-Xuan,et al. Screening for germ‐line mutations in the NF2 Gene , 1995, Genes, chromosomes & cancer.
[33] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[34] H. Döhner,et al. Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.